Caliper Life Sciences, Inc. (CALP) Tops Q3 EPS by 4c, Sales Top Expectations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts CALP Hot Sheet
Price: $10.49 --0%
Financial Fact:
Provision for income taxes: -75K
Today's EPS Names:
COHR, ATS, SICP, More
Financial Fact:
Provision for income taxes: -75K
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
Caliper Life Sciences, Inc. (NASDAQ: CALP) reported Q3 EPS of $0.03, $0.04 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $36.9 million versus the consensus estimate of $35.59 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Black Hills Corp. (BKH) Tops Q3 EPS by 6c, Misses on Revenue; Offers FY26 EPS Guidance
- CoreCivic (CXW) Misses Q3 EPS by 1530c; raises guidance
- Tutor Perini (TPC) Tops Q3 EPS by 92c; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
